ArticleJournal of cardiothoracic surgery2026
Clinical value analysis of long non-coding RNA PVT1 in the diagnosis and prognosis, of acute myocardial infarction with arrhythmia.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTo investigate the diagnostic and prognostic markers for acute myocardial infarction (AMI) complicated by arrhythmia, focusing on the role of the long non-coding RNA PVT1.
methodsThe study cohort included 144 AMI patients with arrhythmia and 153 without. The primary outcome was the occurrence of major adverse cardiovascular and cerebrovascular events (MACCE) during the 21d early rehabilitation nursing intervention. PVT1 expression levels were measured using RT-PCR. The diagnostic value of PVT1 was performed by the receiver operating characteristic (ROC) curve. Kaplan-Meier (KM) curve evaluated the prognostic value of PVT1 for MACCE.
resultsPVT1 expression was significantly higher in AMI patients with arrhythmia. ROC curve analysis showed that PVT1 had a high value (sensitivity = 78.5%, specificity = 75.2%, AUC = 0.843) for diagnosing AMI with arrhythmia. KM analysis indicated poorer survival outcomes in patients with higher PVT1 expression (Log-rank test, P < 0.001). Cox regression analysis identified low LVEF (HR = 2.764, 95%CI = 1.127–6.780) and high PVT1 (HR = 3.802, 95%CI = 1.054–13.709) as independent risk factors for poor prognosis.
conclusionsPVT1 is upregulated in AMI patients with arrhythmia and is associated with poor prognosis. PVT1 may serve as a promising diagnostic and prognostic marker for AMI complicated by arrhythmia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.